Allergan Catalysts Drive Expansion and 4 Stock Analyses to Know Now

Allergan Inc. (NYSE:AGN): Current price $42.45

After rolling their valuation out to 2014, Susquehanna raised their price target for Allergan Inc. shares and keeps an Outperform rating on the name. Susquehanna expects Allergan to be a much better performer in 2013 after underperforming the specialty pharma group in 2012. The firm believes that pipeline catalysts could support multiple expansion in 2013.

Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Get our fresh Feature Stock Pick now!